TREATMENT OF THE METABOLIC-ASSOCIATED FATTY LIVER DISEASE IN PATIENTS WITH METABOLIC SYNDROME

Abstract

The study was conducted at Tashkent medical academy between 2022-2024. The study participated 165 patients with metabolic syndrome with signs of MAFLD also. Patients included to research with age between 45 and 75 years old. All participants were subject to demographic data, clinical, functional and biochemical markers